Curocell Inc. (KOSDAQ:372320)

Market Cap	448.70B
Revenue	n/a
Net Income	n/a
Shares Out	14.20M
EPS	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,029,727
Average Volume	155,384
Open	32,300
Previous Close	31,600
Day's Range	31,850 - 32,700
52-Week Range	19,390 - 43,000
Beta	n/a
RSI	55.92
Earnings Date	Apr 3, 2025

About Curocell

Curocell Inc. develops CAR-T cell therapy for the treatment of cancer. It focuses on the development of CD19 CAR-T for the treatment of lymphoma; and BCMA CAR-T for the treatment of multiple myeloma. The company was incorporated in 2016 and is based in Daejeon, South Korea.

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 2016
• Country: South Korea
• Stock Exchange: KOSDAQ
• Ticker Symbol: 372320